Podiatrists in Kenedy, TX Accepting Medicare
2 Podiatrists found. Showing 1 - 2
 Texas Foot And Ankle Surgical Associates Pllc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 3349 S Highway 181 Ste 6, Kenedy, TX 78119 Phone: 830-491-9211 Fax: 833-471-2992 |
 Dr. Charles White, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 3349 S Highway 181 Ste 6, Kenedy, TX 78119 Phone: 830-491-9211 Fax: 833-471-2992 |
News Archive
Dementia caregivers design robots for alleviating stress and increasing joyful moments
Building robots that can help people with dementia has been a longtime goal for roboticists. Yet until now, no one has sought to survey informal caregivers, such as family members, about what characteristics and roles these robots should have.
Researchers identify CoV Mac1 proteins as a potential SARS-CoV-2 drug target
A recent study by researchers at the University of Kansas and published on the preprint server bioRxiv* reveals that Mac1 protein implicated in the infection process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a strikingly similar structure and activity in all coronaviruses – suggesting that possible future treatments targeting this protein may exert broad antiviral activity.
Special Times Call for Special Measures – InfraTec Responds to the Effects of the Corona Pandemic
With the current corona crisis, the world is facing a multitude of challenges. First and foremost is the protection of public health.
Osiris Therapeutics completes enrollment in Prochymal MSC therapy Phase II trial for type 1 diabetes
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
› Verified 3 days ago